Price of domestic targeted drug sotorasibu (AMG510)

Sotorasib (AMG510), commonly known as Sotorasib, is a revolutionary treatment for lung cancer. As a small molecule targeted drug, the development of sotoraxib marks an important step towards precision treatment of specific gene mutations. Its main mechanism of action is to block the proliferation and growth of tumor cells by inhibiting the activity of KRAS G12C mutant.

Sotorasibu is currently not available in the domestic market, so domestic patients need to obtain the drug through overseas channels. In the overseas pharmaceutical market, Sotolasibu is divided into original drugs and generic drugs. Original drugs, especially the European andHong Kong versions, are quite expensive, often costing tens of thousands of dollars.

In comparison, generic drugs on foreign markets are much more affordable. Especially for generic drugs in Laos, the prices of two major brands, Lucius and Daxiong, have recently been significantly reduced. Today, the prices are only in the range of 1,000 to 2,000 yuan, which greatly reduces the financial pressure on patients. It is worth noting that these generic drugs maintain a high degree of consistency in their pharmaceutical ingredients with the original drugs.

Soteracib's targeting effects focus on theKRAS G12Cmutant in tumor cells. This mutation causes abnormal activation of KRAS protein, leading to abnormal proliferation and survival of tumor cells. Sotoracib specifically binds to the KRAS G12C protein and inhibits its activity, thereby effectively inhibiting the growth and spread of tumor cells.

Sotorasibu is mainly suitable for KRAS G12C mutation-related lung cancer. This mutation is relatively common in lung cancer, and sotoracib is considered a revolutionary treatment option, providing new hope for this urgent treatment problem. In addition, the application of sotorasiib in other solid tumors is also under investigation.

Sotoraxib has demonstrated good safety and clinical activity in clinical trials. As a revolutionary lung cancer treatment drug, it represents a major advancement in the field of tumor treatment. With the further research and expansion of clinical application of sotoracib, we believe it will bring more hope and opportunities to tumor patients and open up a new direction for future personalized cancer treatment.